Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.38 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.37 |
| ▸ | SENP1 | Q9P0U3 | 2/20 | 0.37 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.37 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1054288 | 0.85 | ALDH1A1 (0.45) | ALDH1A1HPGDSENP2SENP1SUMO2 | |
| SCHEMBL5699729 | 0.83 | ALDH1A1 (0.42) | ALDH1A1GAARCE1KDM4EHPGD | |
| SCHEMBL6422123 | 0.81 | HPRT1 (0.47) | ALDH1A1GAARCE1KDM4EHPGD | |
| SCHEMBL56013 | 0.80 | RELA (0.52) | ALDH1A1KDM4EHPGDRAB9ANPC1 | |
| SCHEMBL56012 | 0.80 | RELA (0.52) | ALDH1A1KDM4EHPGDRAB9ANPC1 | |
| SCHEMBL6315513 | 0.77 | CA1 (0.38) | ALDH1A1GAAKDM4ERAB9AKMT2A | |
| SCHEMBL19665032 | 0.73 | RELA (0.47) | ALDH1A1KDM4ERAB9AKMT2ANPC1 | |
| SCHEMBL5834583 | 0.72 | RELA (0.50) | ALDH1A1KDM4EHPGDRAB9AKMT2A | |
| SCHEMBL3765477 | 0.72 | CYP3A4 (0.53) | ALDH1A1GAAHPGDRAB9AKMT2A | |
| SCHEMBL65321 | 0.72 | CYP3A4 (0.53) | ALDH1A1GAAHPGDRAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1090911-B1 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORP (JP) | 2006-08-30 | — | — | EP | claimed |
| US-7049470-B1 | Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2006-05-23 | — | — | US | claimed |
| EP-1090911-A2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2001-04-11 | — | — | EP | claimed |
| EP-1072668-B1 | Organic electroluminescent device | SONY CORP (JP) | 2008-07-30 | — | — | EP | disclosed |
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| EP-1090911-B1 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORP (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | JOLED INC. (JP) | 2006-08-10 | — | — | US | disclosed |
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | JOLED INC. (JP) | 2006-08-10 | — | — | US | disclosed |
| US-7049470-B1 | Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| US-7049470-B1 | Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| US-6495274-B1 | DI-P-AMINOSTYRYL ANTHRACENE SUBSTITUTED WITH CYANO, NITRO OR HALOGEN GROUPS | SONY CORPORATION (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-1090911-A3 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2001-08-08 | — | — | EP | disclosed |
| JP-2001106657-A | BIS(AMINOSTYRYL)ANTHRACENE COMPOUND AND ITS SYNTHETIC INTERMEDIATE, AND THEIR PRODUCTION | SONY CORP | 2001-04-17 | — | — | JP | disclosed |
| EP-1090911-A2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-1090911-A2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-1072668-A2 | Organic electroluminescent device | SONY CORPORATION (JP) | 2001-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | AASDHPPT, DDC, AADAT | ALDH1A1 782/4885GAA 3116/4885RCE1 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.